ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
142.49
16.35
(12.96%)
Closed February 14 4:00PM
143.83
1.34
(0.94%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
142.49
Bid
133.46
Ask
147.00
Volume
1,501,934
137.87 Day's Range 147.68
0.00 52 Week Range 0.00
Market Cap
Previous Close
126.14
Open
138.75
Last Trade
2
@
143
Last Trade Time
Financial Volume
$ 215,406,053
VWAP
143.4191
Average Volume (3m)
-
Shares Outstanding
56,614,385
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
200.64M
Net Profit
-481.45M

About Ascendis Pharma AS

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and ... Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Hellerup, Dnk
Founded
-
Ascendis Pharma AS is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ASND. The last closing price for Ascendis Pharma AS was $126.14. Over the last year, Ascendis Pharma AS shares have traded in a share price range of $ 0.00 to $ 0.00.

Ascendis Pharma AS currently has 56,614,385 shares outstanding. The market capitalization of Ascendis Pharma AS is $7.14 billion.

Ascendis Pharma AS (ASND) Options Flow Summary

Overall Flow

Bullish

Net Premium

126k

Calls / Puts

100.00%

Buys / Sells

50.00%

OTM / ITM

200.00%

Sweeps Ratio

0.00%

ASND Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ASND - Frequently Asked Questions (FAQ)

What is the current Ascendis Pharma AS share price?
The current share price of Ascendis Pharma AS is $ 142.49
How many Ascendis Pharma AS shares are in issue?
Ascendis Pharma AS has 56,614,385 shares in issue
What is the market cap of Ascendis Pharma AS?
The market capitalisation of Ascendis Pharma AS is USD 7.14B
What is the 1 year trading range for Ascendis Pharma AS share price?
Ascendis Pharma AS has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the reporting currency for Ascendis Pharma AS?
Ascendis Pharma AS reports financial results in EUR
What is the latest annual turnover for Ascendis Pharma AS?
The latest annual turnover of Ascendis Pharma AS is EUR 200.64M
What is the latest annual profit for Ascendis Pharma AS?
The latest annual profit of Ascendis Pharma AS is EUR -481.45M
What is the registered address of Ascendis Pharma AS?
The registered address for Ascendis Pharma AS is TUBORG BOULEVARD 12, HELLERUP, 2900
What is the Ascendis Pharma AS website address?
The website address for Ascendis Pharma AS is www.ascendispharma.com
Which industry sector does Ascendis Pharma AS operate in?
Ascendis Pharma AS operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSLKBolt Projects Holdings Inc
$ 1.228
(302.62%)
273.1M
MBRXMoleculin Biotech Inc
$ 1.27
(202.38%)
107.27M
CSAICloudastructure Inc
$ 38.0312
(115.72%)
3.42M
PEVPhoenix Motor Inc
$ 0.5101
(102.34%)
280M
AMODAlpha Modus Holdings Inc
$ 3.605
(95.92%)
125.94M
RFACRF Acquisition Corporation
$ 2.63
(-69.42%)
685.37k
RFACURF Acquisition Corporation
$ 3.17
(-56.93%)
36.61k
HTLMHomesToLife Ltd
$ 4.00
(-56.90%)
1.24M
DGLYDigital Ally Inc
$ 0.0879
(-43.29%)
117.51M
TOIIWOncology Institute Inc
$ 0.024
(-39.09%)
5.96k
MGOLMGO Global Inc
$ 0.835
(82.99%)
739.4M
PEVPhoenix Motor Inc
$ 0.5101
(102.34%)
280M
BSLKBolt Projects Holdings Inc
$ 1.228
(302.62%)
273.1M
INTCIntel Corporation
$ 24.13
(7.34%)
248.66M
NVDANVIDIA Corporation
$ 135.29
(3.16%)
197.44M

ASND Discussion

View Posts
Monksdream Monksdream 12 months ago
ASND new 52=week high
👍️0
Monksdream Monksdream 12 months ago
ASND new 52 week high
👍️0
MiamiGent MiamiGent 1 year ago
What goes down, must go up :)
Hope you banked, monk.
👍️0
Monksdream Monksdream 1 year ago
ASND new 52 week high
👍️0
Monksdream Monksdream 1 year ago
ASND new 52 week high
👍️0
MiamiGent MiamiGent 2 years ago
ASND 161 shares traded in pre-mkt. Take your profits- nobody going to hold up this dilution candidate.
Bearish
👍️0
MiamiGent MiamiGent 2 years ago
ASND After just one day of wooing, ASND is FALLING ...........in love with my short.
Irresistible attraction: fourteen-month delay on average, need for more money and a red market with housing assuring further rate increase.
Quote as of 5/02/2023 2:44PM ET
$86.375 -$0.365 (-0.421%)
Bearish
https://www.bing.com/videos/search?q=you+tube+music+roy+orbison+i%27m+falling&view=detail&mid=17436B40AE02F042D00317436B40AE02F042D003&FORM=VIRE
👍️0
MiamiGent MiamiGent 2 years ago
$ASND
A complete response letter (CRL) from the FDA delays a product’s entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them.
FDA NEWS
Bearish
👍️0
MiamiGent MiamiGent 2 years ago
ASND Net Income -$622,419,000 in 2022

Anyone want to venture a guess when the raise will come?

I'll take a WAG and say within two weeks.
👍️0
MiamiGent MiamiGent 2 years ago
ASND Quote as of 5/02/2023 10:14AM ET

$88.07 +$1.33 (+1.533%)

I'm down -3.22% on my short. Did not choose well- 100% owned by institutions.. not easily budged.
I am counting on red days, 3 day rule, CRL and outside chance of a raise- it's all I got, lol

https://stockcharts.com/h-sc/ui?s=ASND
👍️0
MiamiGent MiamiGent 2 years ago
Short today at 85.34

How long will this languish before possible good news?

Will need to raise more $$
👍️0
crudeoil24 crudeoil24 3 years ago
Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric Growth Hormone Deficiency > ASND
3:46 pm ET August 25, 2021

By Stephen Nakrosis

Ascendis Pharma A/S on Wednesday said the U.S. Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone Deficiency.

The company said Skytrofa, or lonapegsomatropin-tcgd, is the first once-weekly treatment approved to treat Pediatric Growth Hormone Deficiency.

The company also said Skytrofa was approved to treat "pediatric patients one year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone."

The company said the approval includes its Skytrofa Auto-Injector and cartridges, which enable families to store the medicine at room temperature for up to six months.

The company said availability of Skytrofa in the U.S. is expected soon.

Ascendis said it would hold an investor conference call at 4:30 p.m. ET today.


Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
👍️0
crudeoil24 crudeoil24 3 years ago

ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.
👍️0

Your Recent History

Delayed Upgrade Clock